Skip to content
The Nexus
HEALTHJun 23 · 13:30 UTCQUARTZColleen Cabili

FDA is launching a pilot program to shorten early drug trials and counter China

The FDA is launching a pilot program to shorten early drug trials by 6 to 12 months through collaboration with research institutions. The initiative also aims to counter China's influence in drug development.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
FDAorganizationChinaplaceresearch institutionsorganizationdrug trialstopicpilot programtopic
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting